日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE)

一项 II 期随机研究，评估一线卡铂和紫杉醇联合帕博利珠单抗治疗，随后单独使用帕博利珠单抗或联合奈舒帕利维持治疗，用于错配修复功能正常的晚期或复发性子宫内膜癌（PENELOPE）。

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2026.37.e50
Kim, Se Ik; Cho, Hyun-Woong; Choi, Chel Hun; Park, Jeong-Yeol; Lee, Jung Bok; Kim, Jae-Weon; Kim, Byoung-Gie; Kim, John; Lee, Jung-Yun
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2026
文献求助 收藏

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

一线乐伐替尼联合帕博利珠单抗对比化疗治疗晚期子宫内膜癌：一项随机、开放标签的III期试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01326
Marth, Christian; Moore, Richard G; Bidziński, Mariusz; Pignata, Sandro; Ayhan, Ali; Rubio, M Jesús; Beiner, Mario; Hall, Marcia; Vulsteke, Christof; Braicu, Elena Ioana; Sonoda, Kenzo; Wu, Xiaohua; Frentzas, Sophia; Mattar, André; Lheureux, Stephanie; Chen, Xiaojun; Hasegawa, Kosei; Magallanes-Maciel, Manuel; Choi, Chel Hun; Shalkova, Mariia; Kaen, Diego; Wang, Peng-Hui; Berger, Regina; Okpara, Chinyere E; McKenzie, Jodi; Yao, Lili; Orlowski, Robert; Khemka, Vivek; Gilbert, Lucy; Makker, Vicky
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Durvalumab 与医生选择的化疗方案治疗复发性卵巢透明细胞腺癌 (MOCCA/APGOT-OV2/GCGS-OV3)：一项多中心、随机、II 期试验

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0201
Ngoi, Natalie Y L; Choi, Chel Hun; Zhu, Junxian; Lim, Diana; Tan, Tuan Zea; Sun, Haoyang; Heong, Valerie; Ow, Samuel G W; Chay, Wen Yee; Kim, Hee Seung; Lim, Yi Wan; Lim, Siew Eng; Goss, Geraldine; Goh, Jeffrey C; Kim, Jae-Weon; Friedlander, Michael; Tai, Bee Choo; Kim, Kidong; Tan, David S P
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Improved Prognostic Stratification with the FIGO 2023 Staging System in Endometrial Cancer: Real-World Validation in 2969 Patients

采用 FIGO 2023 分期系统改善子宫内膜癌的预后分层：2969 例患者的真实世界验证

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172871
Seo, Jun-Hyeong; Kim, Soo-Min; Lee, Yoo-Young; Kim, Tae-Joong; Lee, Jeong-Won; Kim, Byoung-Gie; Choi, Chel Hun
肿瘤
肿瘤免疫
子宫内膜癌
发表日期：2025
文献求助 收藏

Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study

化疗联合激素疗法治疗既往接受过大量治疗的晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌的疗效和安全性（ELSA/KGOG3049）：一项多中心试点研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142320
Kim, Kidong; Choi, Chel Hun; Park, Sang-Yoon; Kim, Min Kyu; Lee, Keun Ho; Lee, Eun-Ju; Lim, Myong Cheol; Park, Young Han; Kyung, Min Sun; No, Jae Hong; Suh, Dong Hoon; Lee, Jeong-Won; Ahn, Sangjeong; Lee, Banghyun
肿瘤
免疫/内分泌
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Prognostic Impact of Postoperative Systemic Immune-Inflammation Index Changes in Epithelial Ovarian Cancer

术后全身免疫炎症指数变化对上皮性卵巢癌预后的影响

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17213422
Chung, Young Eun; Paik, E Sun; Kim, Minji; Kim, Na-Hyun; Lim, Seongyun; Seo, Jun-Hyeong; Choi, Chel Hun; Kim, Tae-Joong; Lee, Jeong-Won; Lee, Yoo-Young
肿瘤
炎症
肿瘤免疫
炎症/感染
Immunology/Inflammation
卵巢癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines

卵巢癌临床实践指南：韩国妇科肿瘤学会指南更新

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e69
Lee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Lee, Yoo-Young; Suh, Dong Hoon; Kim, Yong Beom
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan

对初始孕激素治疗无反应的非典型子宫内膜增生患者进行延长孕激素治疗的疗效：韩国和台湾两家三级医疗中心的回顾性研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e18
Choi, Chel-Hun; Lee, Yoo-Young; Lai, Yen-Ling; Chang, Koping; Kim, Hyun-Soo; Chen, Jung; Chen, Yu-Li
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study

孤立性或偶发性浆液性输卵管上皮内癌的临床结局和治疗模式：一项多中心回顾性队列研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e68
Kim, Bo Ra; Kim, Se Ik; Kim, Sang Wun; Choi, Chel Hun; Lee, Shin-Wha; Lim, Myong Cheol; Kim, Yun Hwan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients

多梅尼卡：一线MMR缺陷型晚期子宫内膜癌患者接受多斯利单抗治疗与单纯化疗的比较

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2496133
Cherifi, François; Ray-Coquard, Isabelle; Rubio, Maria Jesus; Paoletti, Xavier; Lorusso, Domenica; Choi, Chel Hun; Hasegawa, Kosei; Tan, David Shao Peng; Hudson, Emma; Davis, Alison; Tognon, Germana; Lheureux, Stéphanie; Vardar Key, Mehmet Ali; Kurtz, Jean Emmanuel; Alexandre, Jerome; Joly, Florence
肿瘤
子宫内膜癌
肿瘤免疫
多发性骨髓瘤
发表日期：2025
文献求助 收藏